Ongoing Care Adjustments based on your response
GLP-1 medications, such as tirzepatide, may cause side effects including nausea, vomiting, diarrhea, constipation, and abdominal pain
Supplementary material The Supplementary Material for this article can be found online at: References 1 WilliamsRKarurangaSMalandaBSaeediPBasitABesanconSet al
It is essential to be aware of these potential side effects and seek medical advice from your healthcare provider if you notice any concerning symptoms
Until Retatrutide is approved, the MHRA-licensed weight-loss injections currently available in the UK through prescription remain Mounjaro (tirzepatide) and Wegovy (semaglutide)
Healthcare professionals increasingly recognise that medication alone is insufficient for optimal outcomes